Stock CLS B CLINICAL LASERTHERMIA SYSTEMS AB
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Clinical Laserthermia Systems AB

Equities

CLS B

SE0022049920

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
6.188 SEK +7.02% Intraday chart for Clinical Laserthermia Systems AB +3.32% -77.58%
Jun. 25 Clinical Laserthermia Systems Signs Italian Distribution Deal for Laser Ablation Therapy MT
Jun. 25 Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with Tecnogamma S.r.l CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Clinical Laserthermia Systems Signs Italian Distribution Deal for Laser Ablation Therapy
MT
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with Tecnogamma S.r.l
CI
Clinical Laserthermia Systems AB Announces Completion of Clinical Study At Skane University Hospital
CI
Clinical Laserthermia Systems AB Receives Additional Order for Clearpoint Prism Products Associated to Approximately SEK 7.5 Million
CI
Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue
MT
Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with MTEC Company
CI
Clinical Laserthermia Systems AB Presents Initial Data from the Investigator Initiated Trial at Radboud University Medical Center Using the CLS Transberg System
CI
Clinical Laserthermia Systems Receives Second Order from the National Institutes of Health Clinical Center in the US for its TRANBERG Thermal Therapy System Accessories
CI
Clinical Laserthermia Systems AB Announces Two Patients with Localized Prostate Cancer Have Been Safely Treated with the Tranberg Thermal Therapy System At the San Luigi Gonzaga University Hospital in Turin, Italy
CI
Clinical Laserthermia Systems AB's Subsidiary CLS Americas Signs Agreement with ROSE Urology for Treatment of Prostate Cancer Patients with TRANBERG Thermal Therapy System
CI
Clinical Laserthermia Systems AB Announces Publication of Preclinical Assessment of A Non-Cooled MR Thermometry-Based Neurosurgical Laser Therapy System
CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Clinical Laserthermia Systems Files Patent Extension, Expansion for Non-cooled Laser Applicators
MT
Clinical Laserthermia Systems AB Files A New Patent Application for Expanded and Extended Protection of the Company's Technology for Laser-Based Tissue Ablation Until 2044
CI
Clinical Laserthermia Systems AB Future-Proofs its Core Technology for MRI-Guided Laser Ablation in A New Agreement with Image Guided Therapy SA
CI
Clinical Laserthermia Systems Obtains Marketing Approval for Tranberg Thermal Therapy Portfolio in Singapore
MT
Clinical Laserthermia Systems AB Receives Market Approval for Its TRANBERG Portfolio by HSA in Singapore and Initiates the Process of Commercialization in the Region
CI
Clinical Laserthermia Systems Gets SEK8 Million Order from ClearPoint Neuro; Stocks Rise
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. News Clinical Laserthermia Systems AB
  5. Highlights